open access

Ahead of Print
Letter to the Editor
Published online: 2021-04-21
Submitted: 2020-11-30
Accepted: 2020-12-16
Get Citation

Pulmonary thromboembolism post-COVID convalescent plasma therapy: adding fuel to a smoldering fire!

Vikas Marwah, Robin Choudhary, Deepu Peter, Gaurav Bhati
DOI: 10.5603/ARM.a2021.0022
·
Pubmed: 33881163

open access

Ahead of Print
LETTERS
Published online: 2021-04-21
Submitted: 2020-11-30
Accepted: 2020-12-16

Abstract

The current SARS-CoV-2 pandemic has affected millions worldwide and is still undergoing. The severe form of involvement constitutes ARDS and these patients are prone to develop Pulmonary thromboembolism. COVID Convalescent Plasma is presently used widely in treatment but this comes with an additional risk of Pulmonary thromboembolism which should be considered and appropriate measures should be taken to avoid it. This has rarely been reported in the literature.

Abstract

The current SARS-CoV-2 pandemic has affected millions worldwide and is still undergoing. The severe form of involvement constitutes ARDS and these patients are prone to develop Pulmonary thromboembolism. COVID Convalescent Plasma is presently used widely in treatment but this comes with an additional risk of Pulmonary thromboembolism which should be considered and appropriate measures should be taken to avoid it. This has rarely been reported in the literature.

Get Citation

Keywords

COVID-19; CCP; pulmonary thromboembolism

About this article
Title

Pulmonary thromboembolism post-COVID convalescent plasma therapy: adding fuel to a smoldering fire!

Journal

Advances in Respiratory Medicine

Issue

Ahead of Print

Article type

Letter to the Editor

Published online

2021-04-21

DOI

10.5603/ARM.a2021.0022

Pubmed

33881163

Keywords

COVID-19
CCP
pulmonary thromboembolism

Authors

Vikas Marwah
Robin Choudhary
Deepu Peter
Gaurav Bhati

References (6)
  1. Sakr Y, Giovini M, Leone M, et al. Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review. Ann Intensive Care. 2020; 10(1): 124.
  2. Focosi D, Anderson AO, Tang JW, et al. Convalescent plasma therapy for COVID-19: state of the art. Clin Microbiol Rev. 2020; 12(33): 4791–4797.
  3. Yiğenoğlu TN, Hacıbekiroğlu T, Berber İ, et al. Convalescent plasma therapy in patients with COVID-1. J Clin Apher. 2020; 35(4): 367–373.
  4. Joyner MJ, Wright RS, Fairweather D, et al. Early safety indicators of COVID-19 convalescent plasma in 5000 patients. J Clin Invest. 2020; 130(9): 4791–4797.
  5. Sanfilippo F, La Rosa V, Oliveri F, et al. Convalescent plasma for COVID-19: the risk of pulmonary embolism should not be underestimated! Crit Care . 2020; 24(1): 531.
  6. Nair PM, Rendo MJ, Reddoch-Cardenas KM, et al. Recent advances in use of fresh frozen plasma, cryoprecipitate, immunoglobulins, and clotting factors for transfusion support in patients with hematologic disease. Semin Hematol. 2020; 57(2): 73–82.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Czasopismo Pneumonologia i Alergologia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl